Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 6
2007 53
2008 134
2009 178
2010 249
2011 335
2012 371
2013 437
2014 415
2015 356
2016 297
2017 285
2018 251
2019 269
2020 251
2021 187
2022 127
2023 108
2024 68

Search Results

3,675 results

Results by year

Filters applied: . Clear all
Page 1
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Hoeper MM, Al-Hiti H, Benza RL, Chang SA, Corris PA, Gibbs JSR, Grünig E, Jansa P, Klinger JR, Langleben D, McLaughlin VV, Meyer GMB, Ota-Arakaki J, Peacock AJ, Pulido T, Rosenkranz S, Vizza CD, Vonk-Noordegraaf A, White RJ, Chang M, Kleinjung F, Meier C, Paraschin K, Ghofrani HA, Simonneau G; REPLACE investigators. Hoeper MM, et al. Lancet Respir Med. 2021 Jun;9(6):573-584. doi: 10.1016/S2213-2600(20)30532-4. Epub 2021 Mar 24. Lancet Respir Med. 2021. PMID: 33773120 Clinical Trial.
Do phosphodiesterase-5 inhibitors have a cardioprotective effect?
Facio Junior FN, Querichelli AFA, Santos BDR, Arruda GJF, Spessoto LCF. Facio Junior FN, et al. Rev Assoc Med Bras (1992). 2020 Nov;66(11):1464-1465. doi: 10.1590/1806-9282.66.11.1464. Rev Assoc Med Bras (1992). 2020. PMID: 33295389 Free article. No abstract available.
3,675 results